Topic: Neuroimaging

« Back

Print this page

	Personalized Program The Personalized Program enables you to compile an individual program with events and contributions of your interest. Therefore, it can be used very well to plan your actual congress visit at an early point of time. Please log in to use the Personalized Program.	» Login » Identification » Help

	Sunday, 28. June 2009	next day »

No.	S-05 - Symposium
Time:	08.00-09.30
Room:	Room 241
Topic:	Neuroimaging
Track:	3 Interface
Session title:	Near-infrared spectroscopy (NIRS) in psychiatry: Current status and future prospect
	Masato Fukuda, Japan	Chair
	Andreas J. Fallgatter, Germany	Co-Chair

001	Bilateral frontal activation during a phonological working memory task in schizophrenic patients
	Sohee Park, USA	Speaker
002	Near-infrared spectroscopy in mood disorders
	Masato Fukuda, Japan	Speaker
003	NIRS in Attention-Deficit / Hyperactivity Disorder (ADHD)
	Andreas J. Fallgatter, Germany	Speaker
004	Clinical NIRS application to psychiatric diagnosis and evaluation
	Ryu Takizawa, Japan	Speaker

No.	S-16 - Symposium
Time:	14.00-15.30
Room:	Room 252B
Topic:	Neuroimaging
Track:	1 Basic
Session title:	Advances in the neuroimaging of ADHD
	Joseph Biederman, USA	Chair
	Larry Seidman, USA	Co-Chair

001	Neuroimaging findings implicating fronto-cerebellar circuit abnormalities in the pathophysiology of ADHD
	Eve Valera, USA	Speaker
002	Frontal lobe cortical-limbic deficiencies in adults with ADHD comorbid with bipolar disorder: A cortical thickness MRI analysis
	Nikos Makris, USA	Speaker
003	Pharmacoimaging studies of stimulant formulations in ADHD using positron emission tomography
	Thomas Spencer, USA	Speaker
004	Genetic imaging as a method for identifying pathophysiological heterogeneity in psychiatric disorders: Evidence from ADHD
	Larry Seidman, USA	Speaker

« previous day	Monday, 29. June 2009	next day »

No.	S-27 - Symposium
Time:	08.00-09.30
Room:	Salle Maillot
Topic:	Neuroimaging
Track:	1 Basic
Session title:	Positron emission tomography (PET) and functional magnetic resonance imaging (fMRI) of human brain monoamine neurotransmission
	Nicole Praschak-Rieder, Austria	Chair
	Nathalie Ginovart, Switzerland	Co-Chair

001	Influence of Fenfluramine challenge of Serotonin-2A receptor binding
	Franz Vollenweider, Switzerland	Speaker
002	Effects of SSRIs on brain serotonin function revealed by PET and phfMRI
	Rupert Lanzenberger, Austria	Speaker
003	Brain monoamino-oxidase-A imaging using [11C]harmine and positron emission tomography
	Nathalie Ginovart, Switzerland	Speaker
004	Influence of season and light on human serotonin transporter binding and function
	Matthaeus Willeit, Austria	Speaker

No.	P-19 - Poster Presentation
Time:	12.30-14.00
Room:	Foyer
Topic:	Neuroimaging
Session title:	Neuroimaging I
	Dieter F. Braus, Germany	Chair

001	FDG - PET imaging of patients with amnestic mild cognitive impairment with and without depression
	Effie Mitsis, USA	Presenter
002	Using Effective Connectivity as a marker for Depression Vulnerability
	Christian Kasess, Austria	Presenter
003	Volitional saccades and prefrontal cortical activation in young people at ultra-high risk of psychosis
	Elizabeth Bowman, Australia	Presenter
004	Dissociation of neural networks for anticipation and consumption of social and non-social rewards
	Katja Spreckelmeyer, Germany	Presenter
005	The pathophysiology of schizophrenia: Evidence by Voxel-Based Morphometry and Diffusion Tensor Imaging
	Georgia Karoutzou, Germany	Presenter
006	Progressive MRI findings in schizophrenia
	Jannis Nimatoudis, Greece	Presenter
007	Cortical activations during auditory and non-auditory hallucinations: An fMRI study in childhood- and adult-onset schizophrenia
	Renaud Jardri, France	Presenter
008	Groupage A.B.O, phenotype, rhesus, lewisand schizophrenia
	Benabbas Malik, Algeria	Presenter
009	Brain activation preceding auditory verbal hallucinations
	Kellly Diederen, Netherlands	Presenter
010	Gender differences in [123I]-ADAM binding to Serotonin Transporters in patients with Major Depression before and after treatment with Citalopram
	Konrad Uebelhack, Germany	Presenter
011	Structural differences of gray matter between patients with unipolar and bipolar disorders assessed by voxel-based morphometric analysis
	Yong-Sheng Chen, Taiwan	Presenter
012	Longitudinal changes in brain structure following the first episode of psychosis
	Pilar de Castro Manglano, Spain	Presenter
013	Working memory dysfunction in obsessive - compulsive disorder: A neuropsychological and functional MRI study
	Tomohiro Nakao, Japan	Presenter
014	Disruption of white matter integrity in generalized anxiety disorder: A diffusion weighted imaging study
	Monica Baiano, Italy	Presenter
015	Six months follow-up study of brain levels of γ-aminobutyric acid, glutamate, and glutamine in the first episode schizophrenia patients
	Naoki Goto, Japan	Presenter
016	The neural basis of inhibiting one’s own perspective in psychosis proneness: An fMRI study
	Lisette van der Meer, Netherlands	Presenter
017	Attentional bias and vulnerability for depression: An fMRI study
	Katarina Dedovic, Canada	Presenter
018	The gray matter volume would predict the symptoms change in the patients with major depressive disorder: Mirtazapine vs SSRI
	Sun-Mi Kim, Korea, Republic of	Presenter
019	The neurocircuits in the social anxiety spectrum: A voxel-based investigation
	Maria Ferrari, Brazil	Presenter
020	Regional differences in validity of serotonin transporter occupancy values using PET
	Ulrike Moser, Austria	Presenter

No.	S-38 - Symposium
Time:	16.00-17.30
Room:	Salle Maillot
Topic:	Neuroimaging
Track:	3 Interface
Session title:	Brain imaging in drug development: Traditional nosological versus endophenotype-directed approaches
	Gerhard Gründer, Germany	Chair
	Franz Vollenweider, Switzerland	Co-Chair

001	MRI-based endophenotyping as outset for drug targeting
	Franz Vollenweider, Switzerland	Speaker
002	From nosological to endophenotype-directed drug targeting: The role of PET
	Gerhard Gründer, Germany	Speaker
003	The role of PET in early risk discharge in CNS drug development
	Marc Laruelle, United Kingdom	Speaker
004	Enabling personalized medicine through novel imaging techniques in drug development
	Johannes Tauscher, USA	Speaker

« previous day	Tuesday, 30. June 2009	next day »

No.	FC-16 - Free Communications
Time:	08.00-09.30
Room:	Room 242A
Topic:	Neuroimaging
Session title:	Neuroimaging I
	Eric Hollander, USA	Chair
	Lars Farde, Sweden	Co-Chair

001	The neural correlates of grief due to unrequited love
	Christina Stoessel, Germany	Speaker
002	Investigation of orbitofrontal sulcogyral pattern: Is it possible to distinguish individuals with schizophrenia from those with bipolar disorder?
	Goultchira Chakirova, United Kingdom	Speaker
003	Reproducibility of functional Magnetic Resonance Imaging activations in schizophrenic patients during story comprehension: Impact of task performance
	Olivier Maïza, France	Speaker
004	Emotional modulation of working memory and the influence of the COMT polymorphism
	Sylvia Richter, Germany	Speaker
005	Prefrontal transcranial Direct Current Stimulation (tDCS) modulates resting-state functional connectivity in healthy subjects: A functional magnetic resonance imaging (fMRI) study
	Julie Bor, France	Speaker
006	Structural brain differences between first-episode schizophrenia and first-episode affective psychosis: A population-based magnetic resonance imaging study
	Pedro Rosa, Brazil	Speaker

No.	S-58 - Symposium
Time:	16.00-17.30
Room:	Room 241
Topic:	Neuroimaging
Track:	1 Basic
Session title:	Are there really progressive brain abnormalities in association with schizophrenia? Current longitudinal magnetic resonance imaging studies from at ri
	Geraldo F. Busatto, Brazil	Chair
	René Kahn, Netherlands	Co-Chair

001	Progressive brain changes across the transition to psychosis: Where to from here?
	Stephen J. Wood, Australia	Speaker
002	Brain changes 6 years after the first episode of a psychosis
	Paola Dazzan, United Kingdom	Speaker
003	Brain changes in schizophrenia across the age range
	René Kahn, Netherlands	Speaker
004	Longitudinal MRI investigation of brazilians with first-onset psychosis over 4 years
	Maristela Schaufelberger, Brazil	Speaker

« previous day	Wednesday, 1. July 2009	next day »

No.	FC-24 - Free Communications
Time:	08.00-09.30
Room:	Room 242A
Topic:	Neuroimaging
Session title:	Neuroimaging II
	Thomas Schlaepfer, Germany	Chair
	Jacques Bouchez, France	Co-Chair

001	Microstructural alterations of an orbital and medial prefrontal network in detoxified alcoholics as detected by voxel-based Diffusion Tensor Imaging
	Thomas Peschel, Germany	Speaker
002	Associations between gray matter abnormalities and cognitive function in the at-risk mental state
	Stefan Borgwardt, Switzerland	Speaker
003	Metabotropic Glutamat receptor 5 Imagingin major depressive disorder
	Alexandra Deschwanden, Switzerland	Speaker
004	Depressive symptoms and risk of white matter lesions. The SMART-MR study
	Anne Grool, Netherlands	Speaker
005	Resting state functional MRI and MR-spectroscopy in major depressive disorder: Preliminary results
	Dorothea Irene Horn, Germany	Speaker
006	An fMRI study investigating hippocampal volume, psychological stress and vulnerability for depression
	Katarina Dedovic, Canada	Speaker

No.	S-66 - Symposium
Time:	11.00-12.30
Room:	Blue Amphitheatre
Topic:	Neuroimaging
Track:	1 Basic
Session title:	More insight into auditory verbal hallucinations
	Andre Aleman, Netherlands	Chair
	Iris Sommer, Netherlands	Co-Chair

001	Auditory hallucinations and perceptual mechanisms
	Peter Woodruff, United Kingdom	Speaker
002	Cerebral activity before and during auditory verbal hallucinations
	Iris Sommer, Netherlands	Speaker
003	Self-monitoring and inner speech models of AVH; Is there any evidence?
	Paul Allen, United Kingdom	Speaker
004	Right temporoparietal junction and spatial
	Marion Plaze, France	Speaker

No.	S-67 - Symposium
Time:	11.00-12.30
Room:	Salle Maillot
Topic:	Neuroimaging
Track:	1 Basic
Session title:	Neuroimaging the impulsivity in psychiatry
	Pascale Mazzola-Pomietto, France	Chair
	Eric Hollander, USA	Co-Chair

001	Ventral striatum and impulsivity: fMRI in pathological gambling, OCD, and autism
	Eric Hollander, USA	Speaker
002	Functional neural correlates of inhibitory control in mania and schizophrenia
	Arthur Kaladjian, France	Speaker
003	Genetic and disease related impact on the neural correlates of response inhibition in bipolar disorder
	Sophia Frangou, United Kingdom	Speaker
004	Functional correlates of cognitive control in children with attention-deficit hyperactivity disorder and their unaffected siblings
	Martijn Mulder, Netherlands	Speaker

No.	P-37 - Poster Presentation
Time:	12.30-14.00
Room:	Foyer
Topic:	Neuroimaging
Session title:	Neuroimaging II
	Rupert Lanzenberger, Austria	Chair

001	The functional neuroanatomy of working memory in very preterm born young adults following neonatal brain injury
	Anastasia Kalpakidou, United Kingdom	Presenter
002	Subjective loudness of auditory-verbal hallucinations interferes with processing in brain areas implicated in inner speech
	Ans Vercammen, Netherlands	Presenter
003	Brain [18F]MPPF imaging in eating disorders suggests specific serotoninergic organic background
	Bogdan Galusca, France	Presenter
004	Neural mechanisms of empathy in boys with autism spectrum disorder and their unaffected fathers
	Ellen Greimel, Germany	Presenter
005	Structural covariance in the hallucinating brain modulated by hallucination severity: A voxel-based morphometry study
	Gemma Modinos, Netherlands	Presenter
006	Relationship between glutamate levels and medial temporal function in the At Risk Mental State
	Isabel Valli, United Kingdom	Presenter
007	Fronto-limbic dysfunction in borderline personality disorder: A 18F-FDG Positron Emission Tomography study
	José Salavert Jiménez, Spain	Presenter
008	Individual differences in socio-affective skills influence the neural bases of anger processing
	Lydia Pouga, France	Presenter
009	FDG - PET changes in a patient with neurosyphilis
	Manu Mathews, USA	Presenter
010	Effect of catechol-O-methyltransferase val158met genotype on emotional intelligence and neural activation during emotional processing of words
	Marte Swart, Netherlands	Presenter
011	Imaging serotonin-1A receptor asymmetry in language areas using [carbonyl-11C]WAY-100635 and positron emission tomography
	Martin Fink, Austria	Presenter
012	Is hypometabolism in limbic and neocortical areas a specific feature of dementia? Results from a positron emission tomography study with cognitively normal elders
	Pedro Curiati, Brazil	Presenter
013	Emotional salience of visual scenes enhances repetition suppression in stimulus-related brain regions
	Sarah Zweynert, Germany	Presenter
014	Cerebral involvement in chronic hepatitis C virus infection assessed by magnetic resonance imaging
	Simon Hjerrild, Denmark	Presenter
015	Small amygdala-high aggression: On the role of the amygdala in modulating normal aggression in healthy subjects
	Swantje Matthies, Germany	Presenter
016	Pretreatment MR-scanning in OCD
	Tue Hartmann, Denmark	Presenter
017	A possible biological marker to differentiate between remitted bipolar I and bipolar II disorder using combined FDG-PET brain imaging and executive function assessment
	Tung-Ping Su, Taiwan	Presenter
018	Robust interaction of emotion and cognition in a working memory task with emotional stimuli
	Wolfgang Huf, Austria	Presenter
019	Association between triallelic polymorphism of the serotonin transporter and [18F]MPPF binding potential over 5-HT1A receptor in healthy subjects
	Philippe Gorwood, France	Presenter

No.	FC-30 - Free Communications
Time:	14.00-15.30
Room:	Room 242B
Topic:	Neuroimaging
Session title:	Neuroimaging III
	Bruno Millet, France	Chair
	Matthaeus Willeit, Austria	Co-Chair

001	Ventral striatal activation during reward anticipation correlates with impulsivity in alcoholics
	Jana Wrase, Germany	Speaker
002	Functional connectivity of right insula during self-face processing
	Rajamannar Ramasubbu, Canada	Speaker
003	Two days treatment of auditory hallucinations by high frequency rTMS guided by cerebral imaging: A 6 months follow-up study
	Aurelie Montagne-Larmurier, France	Speaker
004	Intention to communicate in schizophrenia: Functional neuroimaging evidence
	Mary-Claire Hanlon, Australia	Speaker
005	Beyond amygdala: 5-HTTLPR polymorphism and the medial prefrontal cortex
	Cedric Lemogne, France	Speaker
006	Linear and non-linear regional neuroanatomical volume variations due to aging: A voxel-based morphometric MRI study of normal, non-elderly adults
	Pedro Curiati, Brazil	Speaker

No.	S-71 - Symposium
Time:	16.00-17.30
Room:	Salle Maillot
Topic:	Neuroimaging
Track:	1 Basic
Session title:	Catatonia: An update
	Pierre Thomas, France	Chair
	David Cohen, France	Co-Chair

001	Introduction
	Pierre Thomas, France	Speaker
002	Child and adolescent catatonia is associated with an increase in mortallity and morbidity: Evidence from a prospective follow-up study
	David Cohen, France	Speaker
003	Catatonic syndrome in liaison psychiatry: An overview
	Olivier Cottencin, France	Speaker
004	Pathophysiology and the orbitofrontal cortex in Catatonia
	Georg Northoff, Germany	Speaker

« previous day	Thursday, 2. July 2009

No.	S-79 - Symposium
Time:	08.00-09.30
Room:	Room 252B
Topic:	Neuroimaging
Track:	1 Basic
Session title:	Paralimbic determinations and developmental psychiatry
	Jean-Luc Martinot, France	Chair
	Philip McGuire, France	Co-Chair

001	Cortex gyrification in schizophrenia and bipolar patients
	Arnaud Cachia, France	Speaker
002	Pharmaceutical challenges and at-risk subjects
	Philip McGuire, France	Speaker
003	Addiction imaging implication for prevention
	Jean-Luc Martinot, France	Speaker
004	Cognitive reserve Alzheimer's disease and temporal
	David Bartres'Faz, Spain	Speaker

No.	PL-05 - Plenary Lecture
Time:	09.45-10.30
Room:	Main Amphitheatre
Topic:	Neuroimaging
Session title:	Advancements in molecular (PET) imaging provide a cornerstone in future psychiatry research
	Birte Glenthoj, Denmark	Chair

001	Advancements in molecular (PET) imaging provide a cornerstone in future psychiatry research
	Lars Farde, Sweden	Speaker

No.	S-85 - Symposium
Time:	11.00-12.30
Room:	Room 251
Topic:	Neuroimaging
Track:	1 Basic
Session title:	New imaging evidence for illness progression throughout the course of schizophrenia
	Serge Mitelman, USA	Chair
	Monte Buchsbaum, USA	Co-Chair

001	Morphometric evidence of illness progression in schizophrenia
	René Kahn, Netherlands	Speaker
002	Diffusion tensor imaging tractography in schizophrenia
	Thomas Whitford, USA	Speaker
003	Structural brain changes during transition-to-illness phase in individuals at risk for schizophrenia
	Christos Pantelis, Australia	Speaker
004	A longitudinal study of white matter morphometry and organization in chronic schizophrenia
	Serge Mitelman, USA	Speaker

« Back

---